Will booster doses be required for serogroup B meningococcal vaccine?

Will booster doses be required for serogroup B meningococcal vaccine?

The European licensure of 4CMenB, the first vaccine licensed to prevent non-epidemic meningococcal B (MenB) disease, marked an important milestone in the fight against meningococcal disease. However, the potential introduction of 4CMenB into the routine infant schedule is complicated by a number of...

Podrobná bibliografie
Hlavní autoři:	McQuaid, F, Snape, MD
Médium:	Journal article
Jazyk:	English
Vydáno:	2014

Podobné jednotky

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination
Autor: De Whalley, P, a další
Vydáno: (2013)

Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
Autor: de Whalley, P, a další
Vydáno: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
Autor: Snape, MD, a další
Vydáno: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
Autor: Snape, M, a další
Vydáno: (2013)

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease.
Autor: Pollard, A, a další
Vydáno: (2013)

Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.
Autor: McQuaid, F, a další
Vydáno: (2014)

Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
Autor: Khatami, A, a další
Vydáno: (2011)

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
Autor: Su, E, a další
Vydáno: (2011)

Serogroup B meningococcal vaccines-an unfinished story.
Autor: Sadarangani, M, a další
Vydáno: (2010)

Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
Autor: Snape, MD, a další
Vydáno: (2009)

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial.
Autor: Pace, D, a další
Vydáno: (2015)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
Autor: Snape, M, a další
Vydáno: (2015)

Emerging experience with meningococcal serogroup B protein vaccines
Autor: Daniela Toneatto, a další
Vydáno: (2017-05-01)

Meningococcal serogroup B vaccines: Estimating breadth of coverage
Autor: Robert G. K. Donald, a další
Vydáno: (2017-02-01)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine
Autor: Blanchard-Rohner, G, a další
Vydáno: (2012)

Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine.
Autor: Blanchard-Rohner, G, a další
Vydáno: (2012)

A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?
Autor: Martin, N, a další
Vydáno: (2013)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
Autor: Rivero-Calle I, a další
Vydáno: (2019-10-01)

Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
Autor: Snape, MD, a další
Vydáno: (2006)

Challenges and progress in the development of a serogroup B meningococcal vaccine.
Autor: Lewis, S, a další
Vydáno: (2009)

No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales - Authors' reply
Autor: Snape, MD, a další
Vydáno: (2006)

Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction
Autor: Domenico Martinelli, a další
Vydáno: (2015-01-01)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: a follow-on study to a randomized clinical trial.
Autor: Snape, MD, a další
Vydáno: (2013)

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial
Autor: Snape, MD, a další
Vydáno: (2013)

Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
Autor: Snape, M, a další
Vydáno: (2006)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
Autor: Read, R, a další
Vydáno: (2014)

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial
Autor: Read, R, a další
Vydáno: (2014)

Impact of a meningococcal protein-based serogroup B vaccine on serogroup W invasive disease in children
Autor: Marshall, HS, a další
Vydáno: (2020)

Are Physicians Obligated to Tell Parents about the Meningococcal Serogroup B Vaccine?
Autor: Dr Joan L Robinson
Vydáno: (2015-01-01)

Young Adult and Parent Willingness to Pay for Meningococcal Serogroup B Vaccination
Autor: Liping Huang, a další
Vydáno: (2024-08-01)

Meningococcal serogroup B vaccine: Knowledge and acceptability among parents in Italy
Autor: Teresa Morrone, a další
Vydáno: (2017-08-01)

Parental awareness and utilization of meningococcal serogroup B vaccines in the United States
Autor: Amit Srivastava, a další
Vydáno: (2020-07-01)

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)
Autor: I. S. Koroleva, a další
Vydáno: (2022-01-01)

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial.
Autor: Snape, MD, a další
Vydáno: (2010)

Toward an Improved Meningococcal Serogroup B Assay
Autor: Jan Poolman
Vydáno: (2018-07-01)

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.
Autor: Perrett, K, a další
Vydáno: (2012)

Impact of serogroup A meningococcal conjugate vaccine for Africa
Autor: James M. Stuart
Vydáno: (2018-05-01)

The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology
Autor: Luiz Silva JD, a další
Vydáno: (2010-06-01)

Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine.
Autor: Snape, MD, a další
Vydáno: (2005)

Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
Autor: Paul Balmer, a další
Vydáno: (2018-06-01)